ICU delirium trials are flawed based on your astute observation that hyper vs hypoactive deliriums are just not the same entity. There is a complex myriad of difference in neurotransmitters and interactions with neuros which require a corresponding pharmacological intervention which we lack the tools to correctly assess each tjme simply because - we cannot measure neurotransmitters and neuronal interactions readily. This problem has and will contiued to plague the world of neuropathy for the foreseeable future until technically catches up. Until then I don't really take any "positive" ICU delirium trials that seriously
ICU delirium trials are flawed based on your astute observation that hyper vs hypoactive deliriums are just not the same entity. There is a complex myriad of difference in neurotransmitters and interactions with neuros which require a corresponding pharmacological intervention which we lack the tools to correctly assess each tjme simply because - we cannot measure neurotransmitters and neuronal interactions readily. This problem has and will contiued to plague the world of neuropathy for the foreseeable future until technically catches up. Until then I don't really take any "positive" ICU delirium trials that seriously